 |
|
Demonstration of the Presence of Circulating Tumor Cells as Evidence of Metastatic Potential—Reply
Ralf Steinert, MD;
Marc A. Reymond, MD, MBA
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In reply
We thank our colleagues Barreto and Shukla for their interest in our work and for their comments. They are right, the concept of circulating tumor cells is not new. In fact, circulating cells in blood were first described not in 1955 by Engell, but—to our knowledge—in 1917 by Marcus.1
Barreto and Shukla remark that disseminated cells are epithelial cells and that the labeling we used was not tumor-specific. This is correct. However, we had no better choice than these antibodies when our study started in 1997. Moreover, in the meantime, the markers we used have been applied in a large number of prognostic studies on minimal residual disease in various cancers. It is indeed unfortunate that no specific tumor markers are available for immunohistochemical characterization of circulating epithelial cells. This was the reason why our group started early molecular studies . . . [Full Text of this Article]
AUTHOR INFORMATION
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Influence of Subclinical Tumor Spreading on Survival After Curative Surgery for Colorectal Cancer
Ralf Steinert, Marco Hantschick, Michael Vieth, Ingo Gastinger, Frank Kühnel, Hans Lippert, and Marc A. Reymond
Arch Surg. 2008;143(2):122-128.
ABSTRACT
| FULL TEXT
RELATED LETTER
Demonstration of the Presence of Circulating Tumor Cells as Evidence of Metastatic Potential
Savio G. Barreto and Parul J. Shukla
Arch Surg. 2008;143(11):1134.
EXTRACT
| FULL TEXT
|
